Trinity Biotech PLC/ US8964385046 /
2024-04-24 9:39:35 PM | Chg. 0.0000 | Volume | Bid10:00:07 PM | Ask10:00:07 PM | High | Low |
---|---|---|---|---|---|---|
1.8300USD | 0.00% | 11,196 Turnover: 20,237.0004 |
1.8300Bid Size: 500 | 2.5000Ask Size: 1,100 | 1.9130 | 1.8300 |
GlobeNewswire
04-04
Trinity Biotech Announces Fourth Quarter and Fiscal Year 2023 Financial Results & Business Updates
GlobeNewswire
02-07
Trinity Biotech Announces Application for Early Sjogrens Syndrome Test Panel PLA Code
GlobeNewswire
01-31
Trinity Biotech Announces Entry into a Letter of Intent with Bayer for a Joint Partnership to Launch...
GlobeNewswire
01-31
Trinity Biotech Announces Acquisition of the CGM Assets of Waveform Technologies, Inc.
GlobeNewswire
2023-12-27
Trinity Biotech Announces It Has Begun Shipments of Its New HIV Screening Test, TrinScreen HIV to Ke...
GlobeNewswire
2023-11-28
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimu...
GlobeNewswire
2023-10-10
Trinity Biotech Welcomes The Decision Of The High Court Of Kenya To Strike Out The Applications To P...
GlobeNewswire
2023-09-27
Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial Results
GlobeNewswire
2023-09-11
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement
GlobeNewswire
2022-02-14
Trinity Biotech Announces the World Health Organisation Approval Of TrinScreen™ HIV
GlobeNewswire
2022-01-25
Trinity Biotech Announces That Its Shareholders Have Approved All of the Four Resolutions That Were ...